Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. - Test2 - elhamkhani - TriplyDB

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

http://www.wikidata.org/entity/Q34556945

about

Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulation Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy Close association of water channel AQP1 with amyloid-beta deposition in Alzheimer disease brains "Hairy baskets" associated with degenerative Purkinje cell changes in essential tremor Specific and disease stage-dependent episodic memory-related brain activation patterns in Alzheimer’s disease: a coordinate-based meta-analysis Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine Characteristics of Tau and Its Ligands in PET Imaging Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies The role of macropinocytosis in the propagation of protein aggregation associated with neurodegenerative diseases Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias Neuropathological alterations in Alzheimer disease The fornix in mild cognitive impairment and Alzheimer's disease Early etiology of Alzheimer's disease: tipping the balance toward autophagy or endosomal dysfunction?Passive immunization with phospho-tau antibodies reduces tau pathology and functional deficits in two distinct mouse tauopathy models Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8 Spreading of pathology in neurodegenerative diseases: a focus on human studies Legal but lethal: functional protein aggregation at the verge of toxicity Analyzing dendritic spine pathology in Alzheimer's disease: problems and opportunities Argyrophilic grain disease Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48 Rapid changes in phospho-MAP/tau epitopes during neuronal stress: cofilin-actin rods primarily recruit microtubule binding domain epitopes Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly.von Economo neurones are selectively targeted in frontotemporal dementia Trans-synaptic spread of tau pathology in vivo TARDBP 3'-UTR variant in autopsy-confirmed frontotemporal lobar degeneration with TDP-43 proteinopathy Alzheimer’s disease and chronic traumatic encephalopathy: distinct but possibly overlapping disease entities Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline Music application alleviates short-term memory impairments through increasing cell proliferation in the hippocampus of valproic acid-induced autistic rat pups.Superficial siderosis associated with abundant τ and α-synuclein accumulation.Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.Evaluation of alpha-synuclein immunohistochemical methods used by invited experts Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AβPP(L/S) transgenic mice.A 6.4 Mb duplication of the α-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations.Arf6 controls beta-amyloid production by regulating macropinocytosis of the Amyloid Precursor Protein to lysosomes An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability.

P2860

Q21260256-C6BC336F-DB6C-4361-AF43-DB603CB4CA58 Q22251077-65C6651D-653D-4D06-9BB2-14FD4DA643BC Q24317142-1FDF3837-84A2-4032-9FC7-4EFEB4D6D847 Q24628115-4F920853-532A-4378-923D-C63623139B4A Q24758018-7A775297-E652-47FE-A568-7627020F3C60 Q26768648-1CA3250B-AEA0-4C62-9BAD-7F0728A710BE Q26769952-547485FC-4381-43DE-A96C-566545C6B26B Q26769957-30FC4F49-D618-4FF5-924E-A255B3DFE1B4 Q26777240-23868B66-4AA4-4A81-A42C-B77B50BE8D98 Q26801644-1619D00C-328D-4702-9383-D080CF9C5D30 Q26851112-48DB93D4-FD24-475B-AF2C-D43809E7A982 Q27003078-C7773A7E-D7D2-4F58-B11E-D19A0171CD66 Q27003314-8598BE3A-7D79-4E71-9C48-69DD53A6B81F Q27015799-5752B823-051A-4107-8F6F-B6FC55697442 Q27026907-232FEF6B-753F-4E03-8B2A-8E6AEC9B2986 Q27308146-67361836-41EE-40A1-BB06-D93F412C0DF9 Q27703671-AB315C52-85FF-44B3-A707-276482E65006 Q28082279-98FB6883-22C9-4595-A6D0-35AEA841CE53 Q28084859-E4FC8534-B571-43BF-873F-DEA0FED830C7 Q28087158-E708FE8B-570E-42D3-9359-9E88D66C2EBA Q28266563-48B5395A-EB2D-4D4F-9F5C-7AF97F59CC20 Q28297520-B24E206F-8689-4A5C-8C28-A8136C0EAE03 Q28478846-E7EFA5C1-6446-416C-AEF1-CD43C0C3213C Q28572007-FA8550D9-F758-43D5-8566-67E9505914B6 Q28681663-B0372F8C-B799-4433-829B-E3690275E431 Q28732288-480F8212-EA19-44BE-9BA9-AC295B2B0BE2 Q28749802-C0C0A89B-12C4-4E19-B44A-06CECB2B71C2 Q29248301-88C048EA-FED8-4539-9C9E-0A6F446A219D Q30239789-36B391A9-7978-4871-9C25-C83E88497030 Q30390564-FE898D3B-ED60-4DBC-98D6-2F7EA6F029A5 Q30446486-727E327E-25F1-4C3B-A452-54ECF06F100D Q30446918-B056EF3D-7920-4649-9627-4961EA549BA8 Q30483865-9EB2C673-596C-4EDD-A60C-D52A019C2492 Q30488694-60E92EE1-368E-4A23-A2CD-34833B425D1B Q30524688-922AD98F-3543-4262-A54F-3646D4C2DB90 Q30611779-CF84635F-EF96-481D-B8E7-120FBEAB9FD1 Q30628518-170C9BF8-D656-4ED2-81EA-EC6598C4A919 Q30657683-0B0A3F52-DB70-4759-BF42-1B58C7BD36C0 Q30828708-06B8850D-87C9-4266-B2FA-B361740874E6 Q30857122-07C2D1C1-D98C-4DD9-9B53-787D7BD07D9E

P2860

Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

http://www.wikidata.org/entity/Q34556945

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@ast

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@en

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@nl

type

label

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@ast

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@en

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@nl

prefLabel

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@ast

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@en

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@nl

P1433

Q34556945-38A9D24D-A7B8-43F5-B40F-9B047D65897D

P1476

Q34556945-7349257E-E47B-4085-877D-67763B710EB1

P2093

Q34556945-277DFE9C-3274-4E0C-8843-02F8E3E7617C

Q34556945-9A4EC33D-4672-4A50-B0CB-D360E4D42645

Q34556945-D4D56115-5CA9-46D4-B038-21A863618F92

Q34556945-DAE0F8CE-228E-4AA6-BFCD-8754ADED4E00

Q34556945-FA9FE35D-8C42-4E74-B818-CC52D0275764

P2860

Q34556945-02CFA1CE-A7D4-49CE-8CFE-86C459A5087C

Q34556945-0D74A454-2249-45BE-BC5B-9EC29A0D0A3D

Q34556945-106ED9F6-D278-460F-A456-F6B6062A7018

Q34556945-14C14438-5A75-4DCC-BD3E-3EB620A5247E

Q34556945-199265D4-101D-4A58-9279-A2E6321E2213

Q34556945-19D95078-FE5F-4603-B731-A2EB1B420D87

Q34556945-1BEDF1D5-119E-4550-9818-4E35B36BD098

Q34556945-28587904-0B62-4E8B-8DD9-271CD43039E8

Q34556945-2E535750-8883-422D-8743-2B0EA68C4845

Q34556945-2E6537A2-1938-4560-A991-72080DB645E1

P2888

Q34556945-C82686AC-4B8A-44E1-8124-BCAAC3977487

P304

Q34556945-93EAB3B5-25B8-4441-80E6-7BAC7DC59E69

P31

Q34556945-62A23A15-59D5-4DB2-9E1F-EF056A136A55

P356

Q34556945-72432C7A-CCAD-474B-A899-45D5A8B83146

P433

Q34556945-9B02E1E8-3A1F-48FA-A4BE-956123C3C0B6

P478

Q34556945-873BFA30-15F5-4564-80F0-27EEAF44BFD8

P577

Q34556945-EFB59624-6947-4D0E-842B-8958F3A65D4F

P5875

Q34556945-D991BD75-D930-469E-88BA-E4FD029E0CBD

P698

Q34556945-0FD7C45F-B26D-45B8-A033-57F0B12EABE5

P921

Q34556945-83a988ed-5e91-4d88-815d-c986a4245508

Q34556945-E382F593-800D-45C7-A1D0-B33249763F4B

P932

Q34556945-6AC1FF97-1306-4432-9939-725DA7254ABC

P356

S00401-006-0127-Z

P1433

Acta Neuropathologica

P1476

Staging of Alzheimer disease-a ...... tions and immunocytochemistry.

@en

P2093

Hans Kretzschmar

http://www.w3.org/2001/XMLSchema#string

Heiko Braak

http://www.w3.org/2001/XMLSchema#string

Irina Alafuzoff

http://www.w3.org/2001/XMLSchema#string

Kelly Del Tredici

http://www.w3.org/2001/XMLSchema#string

Thomas Arzberger

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathological stageing of Alzheimer-related changes

Neuropathologic features of amnestic mild cognitive impairment

Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

REVIEW: tau protein pathology in Alzheimer's disease and related disorders.

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Stains for the differential diagnosis of degenerative dementias.

The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region

Vulnerability of select neuronal types to Alzheimer's disease.

Comparison of seven staining methods for senile plaques and neurofibrillary tangles in a prospective series of 15 elderly patients.

P2888

s00401-006-0127-z

P304

389-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-006-0127-Z

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2006-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6881897

http://www.w3.org/2001/XMLSchema#string

P698

16906426

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3906709

http://www.w3.org/2001/XMLSchema#string